TolerogenixX GmbH
PrivateLast Round
Series A
Jul 6, 2023
Total Funding Raised
$12.63M
Company Overview
TolerogenixX GmbH is a biopharmaceutical company developing personalized cellular therapies aimed at achieving sustained immune tolerance to combat organ rejection and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TolerogenixX GmbH Comparables
Compare TolerogenixX GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medeor Therapeutics | 85% | |
| Quell Therapeutics | 78% | |
| Cell4Cure AB | 75% | |
TolerogenixX GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 6, 2023 | ||||
| Seed | May 23, 2017 |
TolerogenixX GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| High-Tech Gründerfonds | Series A, Seed |
| Kalodion | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2023
$13M round led by High-Tech Gründerfonds.
- May 23, 2017
Seed round led by High-Tech Gründerfonds.
TolerogenixX GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TolerogenixX GmbH's valuation, stock price, and market status.